• Tue news: Where do Harris and Trump stand on health policy? Medtronic renal denervation coverage. Canada less likely to have drug shortages? Wall Street wants CVS execution plan. Nektar manufacturing facility sale. See more on our front page

FDA Denies Vorapaxar!







It is not going to happen. I watched the advisory meeting where the FDA scientists talked about the robust data in theTIMI study for secondary prevention for MI patients. The drug will be approved. Read the comments from the cardiologists at the meeting.
 




How many slam dunks have we had only to have the ball hit the back of the rim and fly out to half court? I really hope it gets approved, but our track record is shit lately. Keeping fingers crossed but not holding breath